ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2017, Vol. 26 ›› Issue (3): 282-286.DOI: 10.3969/cndt.j.issn.1006-298X.2017.03.018

• 论文 • 上一篇    下一篇

2016 ISPD关于腹膜透析相关腹膜炎防治指南的解读

  

  • 出版日期:2017-06-28 发布日期:2017-06-29

Interpretation of 2016 ISPD guidelines on prevention and treatment of peritonitis in peritoneal dialysis patients

  • Online:2017-06-28 Published:2017-06-29

摘要:

腹膜炎是导致腹膜透析(PD)失败的主要原因之一。置管术和临床侵入性操作前预防性使用抗生素可有效地预防腹膜炎;出口处护理可降低腹膜炎发生率;持续质量改进(CQI)管理理念在PD治疗中对于腹膜炎的预防也有重要作用;抗生素治疗腹膜炎的同时可预防性应用抗真菌药物,避免二重感染。当临床怀疑有腹膜炎时,留取透析液细菌培养标本后应立即经验性使用广谱抗生素治疗,再根据培养与药敏结果调整抗感染治疗方案。本文就最新(2016)ISPD关于PD相关腹膜炎防治指南作一解读。

关键词: 腹膜透析, 腹膜炎, 指南

Abstract:

Peritonitis is one of the most serious complications of peritoneal dialysis (PD), which accounted for technique failure. The recent (2016) guidelines represent that antibiotic prophylaxis prior to catheter insertion and invasive clinic procedures, good exitsite care, the CQI (continuous quality improvement) programs may reduce peritonitis rates. And, prophylactic use of antifungals during antibiotic administration may prevent fungal peritonitis. To prevent delay in treatment, antibiotic therapy should be initiated once the appropriate dialysis effluent specimens have been collected, without waiting for the results of laboratory testing. Subsequently, antibiotic therapy should be adjusted according to the culture results and sensitivities. In this paper, according to the latest ISPD Peritonitis Recommendations, we reviewed the prevention and treatment of PDrelated peritonitis.

Key words: peritoneal dialysis, peritonitis, guidelines